Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NexgenRx Inc. V.NXG

Alternate Symbol(s):  NEGXF

NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.


Stock Price Chart (TSXV:NXG)

Fundamentals Snapshot (TSXV:NXG)

Opinion & Analysis (TSXV:NXG)

No current opinion is available.

Bullboard Posts (TSXV:NXG)

Dividend

-Hopefully the first of many , conservative but that is good. -Management continues to methodically build this company. -This company is...
AuAgLi8 - January 20, 2022

Interesting market action

- Volume multifold from benchmark on October 8/2021. -Looks like someone is intrigued with NexgenRX. -This under the radar company...
AuAgLi8 - October 9, 2021

RE:CFO buys 40,500 shares at $.34

Insiders are scooping up shares big time at $.34
jcorobow - July 8, 2021

A few points from Q1 release

- Revenue up YoY - No CEWS - Administration Fees revenue up YoY - EBITDA margin increased from 20% to 25% YoY Great cost cutting...
jcorobow - May 27, 2021

More good results

-"The RETIREMENT of ALL outstanding DEBT." --Growth in EBITDA and Net Profit. -Draw Your Own conclusions.
AuAgLi8 - May 27, 2021

RE:I wish it would trade

I wouldn't worry too much about the volume - the way I see it the only way im giving up these shares is a takeover.
jcorobow - May 3, 2021